title: [The clinical significance of lung resistance protein (LRP) gene expression in patients with acute leukemia].
abstract: OBJECTIVE
  To investigate the relationship between the expression of lung resistance protein (LRP) gene and drug resistance in patients with acute leukemias (AL).
  
  
  METHODS
  Semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR)was used to examine the expression of LRP gene in AL patients and 15 normal subjects. Beta(2) microglobulin (beta(2)MG) was used as internal reference. LRP/beta(2)MG ratio >or= 0.3 was defined as LRP positive.
  
  
  RESULTS
  The positivity percentage of LRP gene expression in newly diagnosed group was 32.4%. The first complete remission rate was 84.0% and 33.0% in LRP negative and LRP positive patients, respectively. The difference was significant (P < 0.005). The expression level of LRP mRNA and the positivity percentage of LRP in relapsed/refractory group were significantly higher than that in newly diagnosed group (P < 0.01). The expression level of LRP gene in normal subjects and long-term survival groups was very low and correlated with FAB subtypes. The mdr-1 gene was examined simultaneously in 61 AL patients. No significant correlation was found between the expression of LRP and mdr-1 gene (P > 0.5). Coexpression of LRP and mdr-1 genes in the same AL patient might result in the worst prognosis.
  
  
  CONCLUSIONS
  High expression of LRP gene leads to clinical drug resistance and is an unfavorable factor to AL patients of prognosis.
authors.affiliation: Second Affiliated Hospital, Hebei Medical University, Shijiazhuang 050000, China.
authors.forename: J
authors.initials: J
authors.lastname: Ren
authors.forename: Z
authors.initials: Z
authors.lastname: Dong
authors.forename: X
authors.initials: X
authors.lastname: Guo
authors.forename: F
authors.initials: F
authors.lastname: Wang
authors.forename: X
authors.initials: X
authors.lastname: Du
authors.forename: X
authors.initials: X
authors.lastname: Zhang
authors.forename: F
authors.initials: F
authors.lastname: Lin
authors.forename: E
authors.initials: E
authors.lastname: Yao
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D019008:Drug Resistance, Neoplasm; D005260:Female; D015870:Gene Expression; D019450:Genes, MDR; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D020394:Vault Ribonucleoprotein Particles / Q000235:genetics*; D000099187:Major Vault Protein
chemical_list: D009363:Neoplasm Proteins; D020394:Vault Ribonucleoprotein Particles; D000099187:Major Vault Protein